Voloridge Investment Management »

Cerevel Therapeutics Hldng I shares owned by Voloridge Investment Management

Quarter-by-quarter ownership of Cerevel Therapeutics Hldng I (CERE) shares owned by Voloridge Investment Management from 13F filings

Historical chart of Voloridge Investment Management investment in Cerevel Therapeutics Hldng I

Tip: Access up to 7 years of quarterly data

All positions including Cerevel Therapeutics Hldng I held by Voloridge Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cerevel Therapeutics Hldng I by Voloridge Investment Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $38M 900k 42.40
2021-12-31 $1.6M 48k 32.43
2021-09-30 $2.7M 92k 29.50

More positions owned by Voloridge Investment Management

Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Procter & Gamble Company (PG)
Bristol Myers Squibb (BMY)
O'reilly Automotive (ORLY)
AutoZone (AZO)
Snowflake Cl A (SNOW)
Lockheed Martin Corporation (LMT)
Automatic Data Processing (ADP)
Netflix (NFLX)
Hp (HPQ)
Block Cl A (SQ)
Exxon Mobil Corporation (XOM)
Jd.com Spon Adr Cl A (JD)

View all positions for Voloridge Investment Management

Top funds holding Cerevel Therapeutics Hldng I

Perceptive Advisors
venBio Select Advisor
Vanguard Group
Paradigm Biocapital Advisors
Balyasny Asset Management
Alpine Associates Management
Baker Bros. Advisors
Alliancebernstein
Millennium Management
Pentwater Capital Management
CNH Partners
Westchester Capital Management
Voloridge Investment Management
Westfield Capital Management Company
T. Rowe Price Associates

View all funds holding Cerevel Therapeutics Hldng I